Results 121 to 130 of about 341,161 (289)
Behavior of diabetic ketoacidosis in an Intensive Care Unit
Introduction: diabetes mellitus is a health problem, having an impact on all systems and which can trigger episodes of diabetic ketoacidosis. Objective: to characterize clinically and epidemiologically the patients with diabetic ketoacidosis admitted to
Yannky Palenzuela-Ramos +4 more
doaj +2 more sources
Insulin Therapy in Diabetic Hyperglycemic Emergencies
Background: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state are two of the most serious metabolic emergencies in diabetic patients.
Diana Machado Ramírez +1 more
doaj +2 more sources
Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report [PDF]
Xinxin Wo, Xiaoyan Yu, Lingling Miao, Yushan Mao, Keke Tang Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence: Keke Tang, Department of Endocrinology, The ...
Tang K, Wo X, Miao L, Yu X, Mao Y
core
ABSTRACT Background There is a paucity of population‐level data evaluating trends in the proportion of children and youth hospitalised with diabetic ketoacidosis (DKA) at the time of Type 1 diabetes (T1D) diagnosis. Methods National Medicaid (US publicly insured claims), MarketScan (US commercially insured claims) and Clinical Practice Research ...
Chintan V. Dave +6 more
wiley +1 more source
PRECIPITATING FACTORS FOR DIABETIC KETOACIDOSIS
Objective; To determine the frequency of various precipitating factors for Diabetic Ketoacidosis (DKA). Material and Methods: This descriptive, cross-sectional study based on purposive sampling method was conducted at Medical ward VI, Islamabad Hospital,
Danish Naveed +3 more
doaj
ABSTRACT Background Antenatal corticosteroids (ACS) promote foetal lung maturation in pregnancies at risk of preterm birth; however, in gestational diabetes mellitus (GDM), they can exacerbate maternal glycemia and contribute to adverse neonatal outcomes. Clinical guidelines offer limited direction on optimal treatment adjustment.
Alexandra Katz +11 more
wiley +1 more source
ABSTRACT Aims While the new kidney protective therapies have transformed chronic kidney disease (CKD) management in patients with Type 2 diabetes mellitus (T2DM), treatment options for CKD in Type 1 diabetes mellitus (T1DM) have remained unchanged for 30 years, limited to renin–angiotensin system inhibitors (RASis).
Frances Perry +12 more
wiley +1 more source
ABSTRACT Aim To explore adult patients', relatives', and healthcare professionals' experiences of acute deterioration and perceptions of patient/family involvement in raising concerns. Design A collective case study underpinned by implementation science.
Aidín McKinney +3 more
wiley +1 more source
Serum miR‐224‐5p levels are progressively elevated in diabetic nephropathy (DN) and serve as an independent predictor of a decline in eGFR of ≥30% over 2 years. Mechanistically, miR‐224‐5p directly targets PTEN 3’‐UTR, suppressing PTEN and the activation of the AKT pathway in high‐glucose‐stimulated mesangial cells.
Yanxia Gao +3 more
wiley +1 more source

